Item-Level Improvements in Inflammatory Bowel Disease Questionnaire Scores in Patients With Ulcerative Colitis Treated With Tofacitinib Induction Therapy

被引：0
|
作者：
Dubinsky, Marla C. [1 ]
DiBonaventura, Marco [2 ]
Fan, Haiyun [3 ]
Bushmakin, Andrew G. [3 ]
Cappelleri, Joseph C. [4 ]
Maller, Eric [3 ]
Thorpe, Andrew J. [3 ]
Salese, Leonardo [3 ]
Panes, Julian [5 ]
机构：
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[2] Pfizer Inc, New York, NY USA
[3] Pfizer Inc, Collegeville, PA USA
[4] Pfizer Inc, Groton, CT 06340 USA
[5] Hosp Clin Barcelona, IDIBAPS, CIBERehd, Barcelona, Catalonia, Spain
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2019年 / 114卷
关键词：
D O I：
10.14309/01.ajg.0000592340.59713.ab
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
701
引用
收藏
页码：S413 / S413
页数：1
相关论文
共 50 条
  • [21] Association between disease duration and degree of endoscopic improvement in patients with ulcerative colitis treated with tofacitinib
    Sandborn, W. J.
    Gisbert, J. P.
    Modesto, I.
    Su, C.
    Quirk, D.
    Mundayat, R.
    Guo, X.
    Chiorean, M.
    Reinisch, W.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S416 - S418
  • [22] The Prognosis of Ulcerative Colitis Patients Who Are Treated With Corticosteroid in an Academic Inflammatory Bowel Disease Center and Community Hospitals
    Nagahori, Masakazu
    Watanabe, Mamoru
    GASTROENTEROLOGY, 2015, 148 (04) : S267 - S267
  • [23] Questionnaire Survey for Inflammatory Bowel Disease Patients in Japan; A Web-Based Japan, Crohn's Disease, Ulcerative Colitis, Patients Survey
    Matsumoto, Takayuki
    Imai, Keita
    Goda, Yuki
    Fujimitsu, Yuki
    Kajioka, Toshifumi
    Kihara, Hideaki
    Funaki, Yuji
    Imaki, Shigeru
    Ueno, Masato
    CROHNS & COLITIS 360, 2023, 5 (04)
  • [24] Prevalence of Family History of Inflammatory Bowel Disease Among Ulcerative Colitis Patients
    Childers, Ryan E.
    Eluri, Swathi
    Vazquez, Christine
    Bayless, Theodore M.
    Hutfless, Susan
    GASTROENTEROLOGY, 2013, 144 (05) : S649 - S650
  • [25] Obesity and Inflammatory Bowel Disease: Outcomes of Patients in a Pro-inflammatory State on Biologic Therapy for Crohn's Disease and Ulcerative Colitis
    Lin, Steven
    Wang, Christina
    Devore, Zachary
    Brown, Jeremy R. Glissen
    Danford, Christopher
    Feuerstein, Joseph
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S585 - S585
  • [26] Validation of the Mainland Chinese version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for ulcerative colitis and Crohn's disease
    Ren, W. H.
    Lai, M.
    Chen, Y.
    Irvine, E. J.
    Zhou, Y. X.
    INFLAMMATORY BOWEL DISEASES, 2007, 13 (07) : 903 - 910
  • [27] Efficacy of Induction Therapy With High-Intensity Tofacitinib in 4 Patients With Acute Severe Ulcerative Colitis
    Berinstein, Jeffrey A.
    Steiner, Calen A.
    Regal, Randolph E.
    Allen, John, I
    Kinnucan, Jami A. R.
    Stidham, Ryan W.
    Waljee, Akbar K.
    Bishu, Shrinivas
    Aldrich, Leslie B.
    Higgins, Peter D. R.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (05) : 988 - +
  • [28] EFFICACY OF INDUCTION THERAPY WITH HIGH-INTENSITY TOFACITINIB IN 4 PATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS
    Berinstein, Jeffrey
    Steiner, Calen
    Regal, Randolph
    Allen, John
    Kinnucan, Jami
    Stidham, Ryan W.
    Waljee, Akbar K.
    Bishu, Shrinivas
    Aldrich, Leslie
    Higgins, Peter
    GASTROENTEROLOGY, 2019, 156 (03) : S32 - S33
  • [29] EFFICACY OF INDUCTION THERAPY WITH HIGH-INTENSITY TOFACITINIB IN 4 PATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS
    Berinstein, Jeffrey
    Steiner, Calen
    Regal, Randolph
    Allen, John
    Kinnucan, Jami
    Stidham, Ryan W.
    Waljee, Akbar K.
    Bishu, Shrinivas
    Aldrich, Leslie
    Higgins, Peter
    INFLAMMATORY BOWEL DISEASES, 2019, 25 : S22 - S23
  • [30] Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab
    Taxonera, C.
    Estelles, J.
    Fernandez-Blanco, I.
    Merino, O.
    Marin-Jimenez, I.
    Barreiro-de Acosta, M.
    Saro, C.
    Garcia-Sanchez, V.
    Gento, E.
    Bastida, G.
    Gisbert, J. P.
    Vera, I.
    Martinez-Montiel, P.
    Garcia-Moran, S.
    Sanchez, M. C.
    Mendoza, J. L.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (03) : 340 - 348
12345